MAPK Signaling
Activated MAPKs transduce the phosphorylation and activation of MAPK-activated protein kinases (MAPKAPKs), e.g. RSK, MSK, or MNK family, and MK2/3/5. There are three main MAPK families, signal-regulated kinase 1 and 2 (Erk1/2 or p44/42), the c-Jun N-terminal kinases 1-3 (JNK1-3)/ stress activated protein kinases (SAPK1A, 1B, 1C), the p38 isoforms (p38α, β, γ, and δ). ERK signaling is involved in cell division, migration and survival. p38 MAPK and JNK/SAPK pathways are activated by cellular stress. The p38 MAPK pathway regulates cell motility, transcription, and chromatin remodeling. JNK/SAPK signaling affects apoptosis and inflammation. Dysregulation of MAPK pathway results in tumorgenesis and other pathological conditions.
- A3942 XMD17-109Target: ERKSummary: ERK-5 inhibitor
- A3943 XMD8-92Target: ERKSummary: BMK1/ERK5 inhibitor
- C5850 SD 169Summary: selective ATP competitive inhibitor of the MAP kinases p38α and p38β
- B6159 Vacquinol-1Summary: MAPK kinase 4 (MKK4) activator
- B6177 PLX7904Summary: paradox-breaker RAF inhibitor, potent and selective
- B6187 BMS-582949Summary: p38 MAPK inhibitor
- B6188 Pamapimod (R-1503, Ro4402257)Summary: p38 MAPK inhibitor
- B7820 APS-2-79Summary: KSR-dependent MAPK modulator
- A1117 PKA inhibitor fragment (6-22) amideSummary: PKA inhibitor
- C3921 Ulixertinib (hydrochloride)Summary: reversible ERK1/2 inhibitor